The Center for Genetics and Society has been active for about a decade, and at the start of a new one it seems appropriate to take a look back. This is by no means a complete history, but a series of pointers that make a very broad-brush look at the last ten years.
Much more about everything mentioned can be found by searching the website, in addition to the links provided.
- First cloned mules, horses, deer, rats; first genetically modified animal to be sold as a pet, the "Glofish"
- Gene therapy trials cause leukemia in French children
- Sperm and eggs derived from mouse embryonic stem cells
- Spread of commercial advertisements for sex selection
- CGS briefings and meetings in U.S., Paris, Brussels, Strasbourg, Bonn, Berlin, Geneva, Zurich [pdf]; co-sponsors major international conference Within and Beyond the Limits of Human Nature, in Berlin with Heinrich Boell Foundation, IMEW
- In Korea, Hwang Woo Suk claims to have created clonal human embryos, and later to have derived stem cells from them; California voters approve Proposition 71 to fund stem cell research
- Mice genetically modified for increased muscle mass
- Canada enacts Assisted Human Reproduction Law, regulating research and clinical applications involving human eggs, sperm and embryos, and prohibiting the creation of new embryos for research, including cloning; UK authority officially allows the creation of "savior siblings" to act as donors for children suffering from certain diseases
- First Synthetic Biology conference held at MIT
- CGS presents at World Social Forum in Mumbai and at World Congress of Bioethics, in Sydney, Australia [pdf]; with the Committee on Women, Population and the Environment and Our Bodies Ourselves, co-sponsors conference on Gender, Justice and the Gene Age, NYC; issues critical analysis of California's stem cell initiative; organizes symposia with the Century Foundation and the City University of New York; launches Gender, Justice and Human Genetics program [pdf]
- Craig Venter announces replacement of bacterial genome, key step towards artificial life, files patent
- California issues first U.S. public funding of cloning-based stem cell research; Harvard unable to get women to provide eggs for similar research
- Genes for skin color identified and proposed for general use by consumers; egg freezing increasingly available and promoted, despite medical concerns; Texas fertility center offers "custom designed" embryos; new at-home tests allow expectant mother to determine sex of future child at six weeks
- 23andMe set to offer complete personal genomic sequencing, Google invests; launch of direct-to-consumer ads for genetic tests
- CGS conducts briefings in D.C., Amsterdam, South Africa [pdf]; hosts Harvard professor Michael Sandel, author of The Case Against Perfection, at events in Berkeley; roundtable discussions with disability rights and reproductive rights leaders; strong CGS response to iPS announcements: several op-eds, press citations, TV & radio interviews, letters; new website launched
- Genetic Information Nondiscrimination Act (GINA) signed into law in U.S.; consumer genetic testing companies face regulators in California, New York
- Improvements in producing stem cells via reprogramming; Ian Wilmut quits cloning-based stem cell research; first clonal human embryo, first genetically modified human embryo and first animal-human cytoplasmic hybrid embryo
- Reports that IVF greatly increases birth defects, and fertility drugs increase cancer risk; first ovary transplant; eggs grown from five-year-old girls' ovarian tissue; egg freezing becomes more widely available; push for payments for eggs for stem cell research in California, Singapore
- U.S. federal government expands collection of DNA to all people arrested for federal crimes and immigration charges; European court rules against UK DNA database
- CGS's Gender and Justice program becomes an independent organization, Generations Ahead; CGS testifies at U.S. House Foreign Affairs Committee Subcommittee on Terrorism, Nonproliferation and Trade hearing on international regulation of human biotech; invited to meet with members of the Obama transition team in Washington DC; co-publishes Geneticizing Disease: Implications for Racial Health Disparities with Center for American Progress; holds invitational strategy sessions in Washington, New York, Cambridge, San Francisco and Berkeley; op-eds, TV/radio interviews, and citations in major media outlets on many issues; BioPolicy Wiki launched, compiling laws on eight biotechnology practices and positions on five international conventions in 194 countries
Posted in Op-eds & Articles, Pete Shanks's Blog Posts
Comments are now closed for this item.